Banner
Global Transmucosal Drug Delivery Devices Market Report 2024

Transmucosal Drug Delivery Devices Global Market Report 2024 – By Type (Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery), By Drug Type (Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types), By Indication (Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications), By End User (Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals) – Market Size, Trends, And Global Forecast 2024-2033

Transmucosal Drug Delivery Devices Global Market Report 2024

Starting Price : $5000.00 $4000.00 | Pages : 175 | Published : October 2024 | Delivery Time: 2-3 business days | Format : pdf

Need assistance or more information before the purchase?

Enquire Before Buying
Transmucosal Drug Delivery Devices Global Market Report 2024

Proud Members Of

checkslacipN checkaoirsN checkscipN

Transmucosal Drug Delivery Devices Market Definition

Transmucosal drug delivery devices are medical devices designed to deliver drugs through the mucous membranes, such as those in the mouth, nose, or rectum, for rapid absorption into the bloodstream. These devices are used to administer medications that are poorly absorbed by the gastrointestinal tract or that require quick onset of action, such as pain relief or hormone therapy. Their purpose is to bypass the digestive system, providing a more direct and efficient route for drug delivery.

The main types of transmucosal drug delivery devices are passive transmucosal drug delivery and active transmucosal drug delivery devices. Passive transmucosal drug delivery refers to the process where drugs are absorbed through mucous membranes without the use of external energy or active transport mechanisms. The types of drugs available include buccal tablets, oral sprays, sublingual films, wafers, gels, medicated confectionery, and others, used for indications such as pain management, addiction treatment, and hormonal therapies. End users encompass academic and research institutes, pharmaceutical and biotechnology companies, diagnostics laboratories, and hospitals.

Transmucosal Drug Delivery Devices Market Segmentation

The transmucosal drug delivery devices market covered in this report is segmented –

1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery

2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types

3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications

4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals

Global Transmucosal Drug Delivery Devices Market Size 2023 to 2028: Graph

Transmucosal Drug Delivery Devices Market Size 2024 And Growth Rate

The transmucosal drug delivery devices market size has grown strongly in recent years. It will grow from $46.16 billion in 2023 to $50.24 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to the need for rapid relief from angina, the effectiveness of sublingual delivery for quick absorption into the bloodstream, desire to bypass gastrointestinal degradation, development of buccal tablets, the need for non-invasive delivery of peptides and proteins.

Transmucosal Drug Delivery Devices Market Growth Forecast

The transmucosal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $71.69 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to the development of smart drug delivery systems, increased prevalence of chronic diseases, growing focus on personalized medicine, aging population with higher medication needs, and increased awareness. Major trends in the forecast period include expansion in therapeutic applications, customizing drug delivery devices for personalized medicine, regulatory approvals and guidelines, emerging markets, eco-friendly devices, and innovative formulations.

Transmucosal Drug Delivery Devices Market Driver: Growth In Chronic Diseases Propels Transmucosal Drug Delivery Devices Market

The growing prevalence of chronic diseases is expected to propel the growth of the transmucosal drug delivery devices market going forward. A chronic disease refers to a long-lasting condition that typically progresses slowly and persists over time, often requiring ongoing medical management to control symptoms and prevent complications. Chronic diseases are rising as a result of, lifestyle factors, aging populations, environmental factors, healthcare system challenges, and urbanization. Transmucosal drug delivery devices are used in chronic diseases to provide controlled and efficient delivery of medications, ensuring sustained therapeutic levels for managing symptoms and improving patient adherence. For instance, in July 2021, according report published by the International Diabetes Federation (IDF), a Belgium-based national diabetes association, about 537 million people worldwide have diabetes. The number of cases has been increasing over the past few decades, and the IDF predicts 783 million people will have diabetes by 2045 an increase of 46%. Therefore, the increasing prevalence of chronic diseases is driving the growth of the transmucosal drug delivery devices market.

Global Transmucosal Drug Delivery Devices Market Major Players

Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd.

Global Transmucosal Drug Delivery Devices Market Trend: Innovative Technologies Transforming Transmucosal Drug Delivery Devices

Major companies operating in transmucosal drug delivery devices are developing innovative smart platform, such as proprietary transdermal patch delivery platforms that enhance drug absorption and improve patient compliance and convenience. Proprietary transdermal patch delivery platforms refer to specialized technologies owned by companies for administering medications through the skin, ensuring controlled release, and enhanced therapeutic outcomes. For instance, in January 2024, Starton Therapeutics Inc, a US-based biotechnology company, launched STARSILON, a novel proprietary transdermal patch delivery platform, for a longer duration to achieve therapeutic delivery of difficult-to-formulate APIs. It expands transdermal drug delivery options for challenging active pharmaceutical ingredients (APIs), enhancing therapeutic efficacy with sustained delivery rates.

Transmucosal Drug Delivery Devices Market Merger And Acquisition: Difgen Pharmaceuticals Acquires Aveva Drug Delivery Services To Enhance Drug Delivery Capabilities

In April 2023, Difgen Pharmaceuticals, an India-based pharmaceutical company, acquired Aveva Drug Delivery Services for an undisclosed amount. With this acquisition, Difgen Pharmaceuticals aims to enhance its drug delivery capabilities and integrate advanced technologies into its pharmaceutical offerings. Aveva Drug Delivery Services is a US-based company that manufacturers transdermal delivery systems (TDS) and oral dissolvable films (ODF).

Regional Insights For The Global Transmucosal Drug Delivery Devices Market

North America was the largest region in the transmucosal drug delivery devices market in 2023. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the transmucosal drug delivery devices market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The transmucosal drug delivery devices market consists of sales of sublingual sprays, nasal drops, rectal suppositories, and sublingual tablets. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The transmucosal drug delivery devices research report is one of a series of new reports from The Business Research Company that provides transmucosal drug delivery devices market statistics, including the transmucosal drug delivery devices industry's global market size, regional shares, competitors with a transmucosal drug delivery devices market share, detailed transmucosal drug delivery devices market segments, market trends, and opportunities, and any further data you may need to thrive in the transmucosal drug delivery devices industry. This transmucosal drug delivery devices market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

Transmucosal Drug Delivery Devices Market Report Forecast And Analysis
Report AttributeDetails
Market Size Value In 2024 $50.24 billion
Revenue Forecast In 2033 $71.69 billion
Growth Rate CAGR of 9.3% from 2024 to 2033
Base Year For Estimation 2023
Actual Estimates/Historical Data 2018-2023
Forecast Period 2024 - 2028 - 2033
Market Representation Revenue in USD Billion and CAGR from 2024 to 2033
Segments Covered 1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery
2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types
3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, Hospitals
Regional Scope Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
Country Scope The countries covered in the report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
Additional countries that can be covered in the report for an additional fee: Bangladesh, Thailand, Vietnam, Malaysia, Singapore, Philippines, Hong Kong, New Zealand, Mexico, Chile, Argentina, Colombia, Peru, Austria, Belgium, Denmark, Finland, Ireland, Netherlands, Norway, Portugal, Sweden, Switzerland, Czech Republic, Poland, Romania, Ukraine, Saudi Arabia, Israel, Iran, Turkey, UAE, Egypt, Nigeria, South Africa.
Key Companies Profiled Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd.
Customization ScopeRequest for Sample
Pricing And Purchase OptionsExplore Purchase Options

    Table Of Contents

    1. Executive Summary

    2. Transmucosal Drug Delivery Devices Market Characteristics

    3. Transmucosal Drug Delivery Devices Market Trends And Strategies

    4. Transmucosal Drug Delivery Devices Market - Macro Economic Scenario

    4.1. Impact Of High Inflation On The Market

    4.2. Ukraine-Russia War Impact On The Market

    4.3. COVID-19 Impact On The Market

    5. Global Transmucosal Drug Delivery Devices Market Size and Growth

    5.1. Global Transmucosal Drug Delivery Devices Market Drivers and Restraints

    5.1.1. Drivers Of The Market

    5.1.2. Restraints Of The Market

    5.2. Global Transmucosal Drug Delivery Devices Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)

    5.3. Global Transmucosal Drug Delivery Devices Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

    6. Transmucosal Drug Delivery Devices Market Segmentation

    6.1. Global Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Passive Transdermal Drug Delivery

    Active Transdermal Drug Delivery

    6.2. Global Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Buccal Tablets

    Oral Sprays

    Sublingual Films And Wafers

    Gels

    Medicated Confectionery

    Other Drug Types

    6.3. Global Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Pain Management

    Addiction Treatment

    Hormonal Therapies

    Others Indications

    6.4. Global Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    Academic And Research Institutes

    Pharmaceutical And Biotechnology Companies

    Diagnostic Laboratories

    Hospitals

    7. Transmucosal Drug Delivery Devices Market Regional And Country Analysis

    7.1. Global Transmucosal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    7.2. Global Transmucosal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8. Asia-Pacific Transmucosal Drug Delivery Devices Market

    8.1. Asia-Pacific Transmucosal Drug Delivery Devices Market Overview

    Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies

    8.2. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.3. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    8.4. Asia-Pacific Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    9. China Transmucosal Drug Delivery Devices Market

    9.1. China Transmucosal Drug Delivery Devices Market Overview

    9.2. China Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.3. China Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    9.4. China Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

    10. India Transmucosal Drug Delivery Devices Market

    10.1. India Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.2. India Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    10.3. India Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11. Japan Transmucosal Drug Delivery Devices Market

    11.1. Japan Transmucosal Drug Delivery Devices Market Overview

    11.2. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.3. Japan Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    11.4. Japan Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12. Australia Transmucosal Drug Delivery Devices Market

    12.1. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.2. Australia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    12.3. Australia Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13. Indonesia Transmucosal Drug Delivery Devices Market

    13.1. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.2. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    13.3. Indonesia Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14. South Korea Transmucosal Drug Delivery Devices Market

    14.1. South Korea Transmucosal Drug Delivery Devices Market Overview

    14.2. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.3. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    14.4. South Korea Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15. Western Europe Transmucosal Drug Delivery Devices Market

    15.1. Western Europe Transmucosal Drug Delivery Devices Market Overview

    15.2. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.3. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    15.4. Western Europe Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16. UK Transmucosal Drug Delivery Devices Market

    16.1. UK Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.2. UK Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    16.3. UK Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17. Germany Transmucosal Drug Delivery Devices Market

    17.1. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.2. Germany Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    17.3. Germany Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18. France Transmucosal Drug Delivery Devices Market

    18.1. France Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.2. France Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    18.3. France Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19. Italy Transmucosal Drug Delivery Devices Market

    19.1. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.2. Italy Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    19.3. Italy Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20. Spain Transmucosal Drug Delivery Devices Market

    20.1. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.2. Spain Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    20.3. Spain Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21. Eastern Europe Transmucosal Drug Delivery Devices Market

    21.1. Eastern Europe Transmucosal Drug Delivery Devices Market Overview

    21.2. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.3. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    21.4. Eastern Europe Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22. Russia Transmucosal Drug Delivery Devices Market

    22.1. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.2. Russia Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    22.3. Russia Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23. North America Transmucosal Drug Delivery Devices Market

    23.1. North America Transmucosal Drug Delivery Devices Market Overview

    23.2. North America Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.3. North America Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    23.4. North America Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24. USA Transmucosal Drug Delivery Devices Market

    24.1. USA Transmucosal Drug Delivery Devices Market Overview

    24.2. USA Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.3. USA Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    24.4. USA Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25. Canada Transmucosal Drug Delivery Devices Market

    25.1. Canada Transmucosal Drug Delivery Devices Market Overview

    25.2. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.3. Canada Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    25.4. Canada Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26. South America Transmucosal Drug Delivery Devices Market

    26.1. South America Transmucosal Drug Delivery Devices Market Overview

    26.2. South America Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.3. South America Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    26.4. South America Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27. Brazil Transmucosal Drug Delivery Devices Market

    27.1. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.2. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    27.3. Brazil Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28. Middle East Transmucosal Drug Delivery Devices Market

    28.1. Middle East Transmucosal Drug Delivery Devices Market Overview

    28.2. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.3. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    28.4. Middle East Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29. Africa Transmucosal Drug Delivery Devices Market

    29.1. Africa Transmucosal Drug Delivery Devices Market Overview

    29.2. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.3. Africa Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    29.4. Africa Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

    30. Transmucosal Drug Delivery Devices Market Competitive Landscape And Company Profiles

    30.1. Transmucosal Drug Delivery Devices Market Competitive Landscape

    30.2. Transmucosal Drug Delivery Devices Market Company Profiles

    30.2.1. Johnson & Johnson

    30.2.1.1. Overview

    30.2.1.2. Products and Services

    30.2.1.3. Strategy

    30.2.1.4. Financial Performance

    30.2.2. Bayer AG

    30.2.2.1. Overview

    30.2.2.2. Products and Services

    30.2.2.3. Strategy

    30.2.2.4. Financial Performance

    30.2.3. Sanofi SA

    30.2.3.1. Overview

    30.2.3.2. Products and Services

    30.2.3.3. Strategy

    30.2.3.4. Financial Performance

    30.2.4. Bristol-Myers Squibb Company

    30.2.4.1. Overview

    30.2.4.2. Products and Services

    30.2.4.3. Strategy

    30.2.4.4. Financial Performance

    30.2.5. Abbott Laboratories

    30.2.5.1. Overview

    30.2.5.2. Products and Services

    30.2.5.3. Strategy

    30.2.5.4. Financial Performance

    31. Transmucosal Drug Delivery Devices Market Other Major And Innovative Companies

    31.1. Novartis AG

    31.2. Becton Dickinson and Company

    31.3. Viatris Inc.

    31.4. Teva Pharmaceutical Industries Ltd.

    31.5. Catalent Inc.

    31.6. AptarGroup

    31.7. Glenmark Pharmaceuticals Limited

    31.8. Stevanato Group S.p.A

    31.9. Lifevision Healthcare Private Limited

    31.10. Noven Pharmaceuticals

    31.11. SAVA Healthcare Limited

    31.12. Antares Pharma Inc.

    31.13. Kaizen Pharmaceuticals Pvt. Ltd.

    31.14. Lucky Pharma Pvt. Ltd.

    31.15. Maya Biotech Pvt. Ltd

    32. Global Transmucosal Drug Delivery Devices Market Competitive Benchmarking

    33. Global Transmucosal Drug Delivery Devices Market Competitive Dashboard

    34. Key Mergers And Acquisitions In The Transmucosal Drug Delivery Devices Market

    35. Transmucosal Drug Delivery Devices Market Future Outlook and Potential Analysis

    35.1 Transmucosal Drug Delivery Devices Market In 2028 - Countries Offering Most New Opportunities

    35.2 Transmucosal Drug Delivery Devices Market In 2028 - Segments Offering Most New Opportunities

    35.3 Transmucosal Drug Delivery Devices Market In 2028 - Growth Strategies

    35.3.1 Market Trend Based Strategies

    35.3.2 Competitor Strategies

    36. Appendix

    36.1. Abbreviations

    36.2. Currencies

    36.3. Historic And Forecast Inflation Rates

    36.4. Research Inquiries

    36.5. The Business Research Company

    36.6. Copyright And Disclaimer

List Of Tables

    Table 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Table 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Table 3: Global Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 4: Global Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 5: Global Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 6: Global Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 7: Global Transmucosal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 8: Global Transmucosal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 9: Asia-Pacific, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 10: Asia-Pacific, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 11: Asia-Pacific, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 12: China, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 13: China, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 14: China, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 15: India, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 16: India, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 17: India, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 18: Japan, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 19: Japan, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 20: Japan, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 21: Australia, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 22: Australia, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 23: Australia, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 24: Indonesia, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 25: Indonesia, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 26: Indonesia, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 27: South Korea, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 28: South Korea, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 29: South Korea, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 30: Western Europe, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 31: Western Europe, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 32: Western Europe, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 33: UK, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 34: UK, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 35: UK, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 36: Germany, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 37: Germany, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 38: Germany, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 39: France, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 40: France, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 41: France, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 42: Italy, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 43: Italy, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 44: Italy, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 45: Spain, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 46: Spain, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 47: Spain, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 48: Eastern Europe, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 49: Eastern Europe, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 50: Eastern Europe, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 51: Russia, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 52: Russia, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 53: Russia, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 54: North America, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 55: North America, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 56: North America, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 57: USA, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 58: USA, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 59: USA, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 60: Canada, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 61: Canada, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 62: Canada, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 63: South America, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 64: South America, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 65: South America, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 66: Brazil, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 67: Brazil, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 68: Brazil, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 69: Middle East, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 70: Middle East, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 71: Middle East, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 72: Africa, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 73: Africa, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 74: Africa, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Table 75: Johnson & Johnson Financial Performance
  • Table 76: Bayer AG Financial Performance
  • Table 77: Sanofi SA Financial Performance
  • Table 78: Bristol-Myers Squibb Company Financial Performance
  • Table 79: Abbott Laboratories Financial Performance

List Of Figures

    Figure 1: Global Historic Market Growth, 2018-2023, $ Billion
  • Figure 2: Global Forecast Market Growth, 2023-2028F, 2033F, $ Billion
  • Figure 3: Global Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 4: Global Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 5: Global Transmucosal Drug Delivery Devices Market, Segmentation By Indication, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 6: Global Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 7: Global Transmucosal Drug Delivery Devices Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 8: Global Transmucosal Drug Delivery Devices Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 9: Asia-Pacific, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 10: Asia-Pacific, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 11: Asia-Pacific, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 12: China, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 13: China, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 14: China, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 15: India, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 16: India, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 17: India, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 18: Japan, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 19: Japan, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 20: Japan, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 21: Australia, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 22: Australia, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 23: Australia, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 24: Indonesia, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 25: Indonesia, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 26: Indonesia, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 27: South Korea, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 28: South Korea, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 29: South Korea, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 30: Western Europe, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 31: Western Europe, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 32: Western Europe, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 33: UK, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 34: UK, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 35: UK, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 36: Germany, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 37: Germany, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 38: Germany, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 39: France, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 40: France, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 41: France, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 42: Italy, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 43: Italy, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 44: Italy, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 45: Spain, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 46: Spain, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 47: Spain, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 48: Eastern Europe, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 49: Eastern Europe, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 50: Eastern Europe, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 51: Russia, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 52: Russia, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 53: Russia, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 54: North America, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 55: North America, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 56: North America, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 57: USA, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 58: USA, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 59: USA, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 60: Canada, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 61: Canada, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 62: Canada, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 63: South America, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 64: South America, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 65: South America, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 66: Brazil, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 67: Brazil, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 68: Brazil, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 69: Middle East, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 70: Middle East, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 71: Middle East, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 72: Africa, Transmucosal Drug Delivery Devices Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 73: Africa, Transmucosal Drug Delivery Devices Market, Segmentation By Drug Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 74: Africa, Transmucosal Drug Delivery Devices Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Figure 75: Johnson & Johnson Financial Performance
  • Figure 76: Bayer AG Financial Performance
  • Figure 77: Sanofi SA Financial Performance
  • Figure 78: Bristol-Myers Squibb Company Financial Performance
  • Figure 79: Abbott Laboratories Financial Performance
View Report
View Report
View Report
View Report
View Report
View Report
View Report
View Report

Frequently Asked Questions

What is the definition of the transmucosal drug delivery devices market?

Transmucosal drug delivery devices are medical devices designed to deliver drugs through the mucous membranes, such as those in the mouth, nose, or rectum, for rapid absorption into the bloodstream. These devices are used to administer medications that are poorly absorbed by the gastrointestinal tract or that require quick onset of action, such as pain relief or hormone therapy. Their purpose is to bypass the digestive system, providing a more direct and efficient route for drug delivery. For further insights on the transmucosal drug delivery devices market, request a sample here

How will the transmucosal drug delivery devices market drivers and restraints affect the transmucosal drug delivery devices market dynamics? What forces will shape the transmucosal drug delivery devices industry going forward?

The transmucosal drug delivery devices market major growth driver - Growth In Chronic Diseases Propels Transmucosal Drug Delivery Devices Market. For further insights on the transmucosal drug delivery devices market, request a sample here

What is the forecast market size or the forecast market value of the transmucosal drug delivery devices market?

The transmucosal drug delivery devices market size has grown strongly in recent years. It will grow from $46.16 billion in 2023 to $50.24 billion in 2024 at a compound annual growth rate (CAGR) of 8.8%. The growth in the historic period can be attributed to the need for rapid relief from angina, the effectiveness of sublingual delivery for quick absorption into the bloodstream, desire to bypass gastrointestinal degradation, development of buccal tablets, the need for non-invasive delivery of peptides and proteins. The transmucosal drug delivery devices market size is expected to see strong growth in the next few years. It will grow to $71.69 billion in 2028 at a compound annual growth rate (CAGR) of 9.3%. The growth in the forecast period can be attributed to the development of smart drug delivery systems, increased prevalence of chronic diseases, growing focus on personalized medicine, aging population with higher medication needs, and increased awareness. Major trends in the forecast period include expansion in therapeutic applications, customizing drug delivery devices for personalized medicine, regulatory approvals and guidelines, emerging markets, eco-friendly devices, and innovative formulations. For further insights on the transmucosal drug delivery devices market, request a sample here

How is the transmucosal drug delivery devices market segmented?

The transmucosal drug delivery devices market is segmented
1) By Type: Passive Transdermal Drug Delivery, Active Transdermal Drug Delivery
2) By Drug Type: Buccal Tablets, Oral Sprays, Sublingual Films And Wafers, Gels, Medicated Confectionery, Other Drug Types
3) By Indication: Pain Management, Addiction Treatment, Hormonal Therapies, Others Indications
4) By End User: Academic And Research Institutes, Pharmaceutical And Biotechnology Companies, Diagnostic Laboratories, HospitalsFor further insights on the transmucosal drug delivery devices market,
request a sample here

Which region has the largest share of the transmucosal drug delivery devices market? What are the other regions covered in the report?

North America was the largest region in the transmucosal drug delivery devices market in 2023. The regions covered in the transmucosal drug delivery devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. For further insights on the transmucosal drug delivery devices market, request a sample here.

Who are the major players in the transmucosal drug delivery devices market?

Major companies operating in the transmucosal drug delivery devices market are Johnson & Johnson, Bayer AG, Sanofi SA, Bristol-Myers Squibb Company, Abbott Laboratories, Novartis AG, Becton Dickinson and Company, Viatris Inc., Teva Pharmaceutical Industries Ltd., Catalent Inc., AptarGroup, Glenmark Pharmaceuticals Limited, Stevanato Group S.p.A, Lifevision Healthcare Private Limited, Noven Pharmaceuticals, SAVA Healthcare Limited, Antares Pharma Inc., Kaizen Pharmaceuticals Pvt. Ltd., Lucky Pharma Pvt. Ltd., Maya Biotech Pvt. Ltd, AdvaCare Pharma LLP, Satsuma Pharmaceuticals Inc., Biophar Lifesciences Private Limited, Fibovil Pharmaceuticals Private Limited, Slan Medicinal Holdings Ltd. For further insights on the transmucosal drug delivery devices market, request a sample here.

What are the key trends in the transmucosal drug delivery devices market?

Major trend in the transmucosal drug delivery devices market - Innovative Technologies Transforming Transmucosal Drug Delivery Devices. For further insights on the transmucosal drug delivery devices market, request a sample here.

What are the major opportunities in the transmucosal drug delivery devices market? What are the strategies for the transmucosal drug delivery devices market?

For detailed insights on the major opportunities and strategies in the transmucosal drug delivery devices market, request a sample here.

How does the transmucosal drug delivery devices market relate to the overall economy and other similar markets?

For detailed insights on transmucosal drug delivery devices market's relation to the overall economy and other similar markets, request a sample here.

What are the latest mergers and acquisitions in the transmucosal drug delivery devices industry?

For detailed insights on the mergers and acquisitions in the transmucosal drug delivery devices industry, request a sample here.

What are the key dynamics influencing the transmucosal drug delivery devices market growth? SWOT analysis of the transmucosal drug delivery devices market.

For detailed insights on the key dynamics influencing the transmucosal drug delivery devices market growth and SWOT analysis of the transmucosal drug delivery devices industry, request a sample here.